, all consecutive patients who received rotational atherectomy for heavily calcified left main coronary disease in our cath lab were enrolled. All clinical and angiographic characteristics as well as information regarding rotational atherectomy and cutting balloon were retrieved and analyzed.
METHODS From January 2012 to December 2013, all consecutive patients who received rotational atherectomy for heavily calcified left main coronary disease in our cath lab were enrolled. All clinical and angiographic characteristics as well as information regarding rotational atherectomy and cutting balloon were retrieved and analyzed.
RESULTS A total number of 8 patients were recruited with a mean age 77.6 +/-9. There were 75% presented with stable angina, 12.5% with acute coronary syndrome and 12.5% with cardiogenic shock. Chronic renal disease was seen in 25%, diabetes mellitus in 50% and hypertension in 100%. The angiographic and procedural success rate was 100%. The number of burrs used per patient was 1.3+/-0.4 and burr size was 1.75+/-0.25. The cutting balloon size was 2.34+/-0.7. Most stents were drug-eluting stent 87%. The techniques used for bifurcation stenting were culotte (62.5%), mini-crush (25%) and provisional (12.5%). Intra-aortic balloon pump was used in 25%. There was no complication among our cases.
CONCLUSION Heavily calcified left main coronary disease treated with rotational atherectomy, cutting balloon and stent is feasible and safe with high angiographic and procedural success rate. BACKGROUND The mortality of patients (pts) admitted with acute myocardial infarction (AMI) remains high despite improvement in all aspects of cardiac care. This mortality is even higher in pts who require index left main (LM) revascularization at the time of admission. We sought to investigate the predictors of in-hospital and 2-year mortality in such pts.
METHODS
This study is single center, retrospective, observational and registry-based study. All pts admitted for AMI as defined in the "Third Universal Definition of Myocardial Infarction" and fulfilled the inclusion and exclusion criteria was enrolled. A total of 212 AMI pts were screened from our institutional LM stenting registry and we identified 75 pts among this cohort who successfully underwent emergency revascularization of the LM disease.
RESULTS A total of 75 AMI pts with significant LM disease were enrolled. Male was in 77.3%. There were 47 (62.7%) ST-segment elevation myocardial infarction (STEMI). Cardiogenic shock was present in 12.0% of the pts and significant number of pts required IABP insertion. Clinical and Angiographic success was achieved in 100% of the patients. Overall, the in-hospital mortality remained high at 17.3% due to overt heart failure, cardiogenic shock and multi-organs function. 13 Major cardiovascular events (MACE) were recorded during hospitalization including death, myocardial infarction, and stent thrombosis and target vessel revascularization. From the multiple regression analysis, cardiogenic shock at presentation and the renal dysfunction remained a good predictor of in-hospital and 2-year mortality for in-hospital survivors. Prognosis for pts in cardiogenic shock remained grave with 77.8% of in-hospital mortality. At 2-year follow up, in-hospital survivor has a mortality of 11.3%whereas additional 22 experienced MACE.
CONCLUSION Pts with LM disease required stenting at the time of AMI is uncommon but is associated with high in-hospital and 2-years mortality especially in those presenting with cardiogenic shock and renal dysfunction. BACKGROUND Final kissing balloon inflation (KBI) is generally accepted as a technique to expand the side branch (SB) and proximal main vessel (MV) simultaneously after cross-over stenting in the coronary bifurcation lesion. The prior bench testing, however, revealed that the KBI causes an asymmetric oval deformation of the proximal MV stent. The Glider balloon (GB) (Tri Reme Medical, Pleasanton, CA, U.S.A) is a dedicated SB balloon designed for optimal SB ostial expansion with minimizing the MV stent deformation. We investigated the efficacy of the GB in the present study.
We analyzed consecutive 19 patients who undertook elective bifurcation stenting with SB dilation using the GB and proximal optimization technique (POT) (mean age; 71 AE 2 year-old, man / female ¼ 17 / 2). The lesion location was LMT / LAD / LCx / RCA ¼ 9 / 7 / 1 / 2. The 2.5 / 4 mm and 3.0/ 4 mm GB balloons were used in 12 and 7 cases, respectively. We evaluated the eccentricity index (short / long lumen diameter) and cross sectional area (CSA) in the SB ostium, proximal and distal MV at the bifurcation and the reference sites using IVUS or OCT or OFDI. RESULTS Procedure success was achieved in all patients. The Pre-PCI diameter stenoses for the main branch and for the side branch were 85 AE 12% and 80AE10%, respectively. They became 5AE7% and 15AE10% immediately after the procedure and 15AE6% and 30AE10% at 6-12 month follow-up. Dissection of the posterolateral branch with residual restenosis of 60% occurred in one patient during dilatation with DEB, which was treated with DES with good result. No acute or sub-acute thrombosis was noticed in any of the studied patients. The incidences of restenosis and of major adverse cardiac events at follow-up were 5% and 6.25%, respectively. Restenosis occurred in 2 patients with circumflex/obtuse marginal and in 2 patients with left anterior descending /diagonal dilatation. 2 were treated with coronary artery bypass surgery and the other two were treated medically. No death was observed in any of the studied patients during the 12 month follow-up period.
RESULTS
CONCLUSION This study demonstrates that the technique of using DES for the main branch and DEB for the side branch for the treatment of bifurcational lesions is safe and effective with a low incidence of restenosis and major adverse cardiac events at immediate and sixtwelve months follow-up. METHODS A total of 3041 patients with significant ULMCA stenosis were enrolled in ASAN-MAIN registry. We identified 861 (28.3%) with ULMCA treatment with DES, who were categorized into stenting with AO coverage (AOC, N¼623) versus stenting without AOC (N¼238). CONCLUSION AOC of the ULMCA with DES is safe, which did not affect clinical outcomes or ISR. METHODS BALB/c AMI mice were systemically treated with CCR2 antagonist (RS504393, 2mg/kg, Tocris) or normal saline (controlgroup). 10 5 EdU-labeled (Invitrogen) MSCs were administered to mice in both groups by intramyocardial injection. We used Tunel kits (R&D Systems) to identify the apoptotic cardiomyocytes in the infarct zone. And slides of the infarcts were stained with Wheat Germ Agglutinin (Invitrogen) to measure vessel density. Anti-Myosin Heavy Chain eFluor 660 (eBioscience) was utilized to measure cardiac myosin-positive area. Transwell chambers (Corning) were introduced to examine the interactions between MSCs and Ly6C high monocytes. Inflammatory cytonkines expressed by Ly6C high monocytes and SDF-1 secreted by MSCs were detected with Elisa Kits (R&DSystems). MSCs viability was further 

